| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | FLUOXETINE | 5 |
| 2 | FLUOXETINE HYDROCHLORIDE | 5 |
| 3 | GABAPENTIN | 5 |
| 4 | IBUPROFEN | 5 |
| 5 | LEVOTHYROXINE SODIUM | 5 |
| 6 | METFORMIN | 5 |
| 7 | METHOTREXATE | 5 |
| 8 | METHOTREXATE SODIUM | 5 |
| 9 | CALCIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 1 | PHENAZOPYRIDINE | 2 | 0.0005 |
| 2 | TIOPRONIN | 1 | 0.0004 |
| 3 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 4 | CARBOXYMETHYLCELLULOSE SODIUM | 2 | 0.0004 |
| 5 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 | 0.0003 |
| 6 | ESLICARBAZEPINE ACETATE | 1 | 0.0003 |
| 7 | CLADRIBINE | 3 | 0.0003 |
| 8 | SPARSENTAN | 2 | 0.0003 |
| 9 | LEVALBUTEROL HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 1 | Benzodiazepine [EPC] | 9 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 7 |
| 3 | Insulin Analog [EPC] | 6 |
| 4 | Anti-epileptic Agent [EPC] | 5 |
| 5 | Corticosteroid [EPC] | 5 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 5 |
| 7 | Proton Pump Inhibitor [EPC] | 5 |
| 8 | Thiazide Diuretic [EPC] | 5 |
| 9 | Calcium [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Reducing and Complexing Thiol [EPC] | 1 | 0.0004 |
| 1 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 2 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 5 | Intestinal Lipase Inhibitor [EPC] | 2 | 0.0001 |
| 6 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 7 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 9 | Insulin [EPC] | 3 | 0.0001 |